Owan TE, Red eld MM. Epidemiology of diastolic heart failure. Prog Cardiovasc Dis 2005;47:320 32. 44. The Booming Dynamics of Aging: From Awareness to Action. The White House Conference on Aging. Washington, DC: US Department of Health and Human Services; 2011. 45. Bahrami H, Kronmal R, Bluemke DA, et al. Differences in the incidence of congestive heart failure by ethnicity: the Multi-Ethnic Study of Atherosclerosis. Arch Intern Med 2008;168:2138 45. 46. Lloyd-Jones DM, Larson MG, Leip EP, et al. Lifetime risk for devel- oping congestive heart failure: the Framingham Heart Study. Circulation 2002;106:3068 72. 47. Loehr LR, Rosamond WD, Chang PP, et al. Heart failure incidence and survival (from the Atherosclerosis Risk in Communities study). Am J Cardiol 2008;101:1016 22. 48. Butman SM, Ewy GA, Standen JR, et al. Bedside cardiovascular examination in patients with severe chronic heart failure: importance of rest or inducible jugular venous distension. J Am Coll Cardiol 1993;22: 968 74. 49. Drazner MH, Rame JE, Stevenson LW, et al. Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure. N Engl J Med 2001;345:574 81. 50. Drazner MH, Hellkamp AS, Leier CV, et al. Value of clinician assess- ment of hemodynamics in advanced heart failure: the ESCAPE trial. Circ Heart Fail 2008;1:170 7. JACC Vol. 62, No. 16, 2013 Yancy et al. October 15, 2013:1495 539 2013 ACCF/AHA Heart Failure Guidelines: Executive Summary 51. Stevenson LW, Perloff JK. The limited reliability of physical signs for estimating hemodynamics in chronic heart failure. JAMA 1989;261: 884 8. 52. Aaronson KD, Schwartz JS, Chen TM, et al. Development and prospective validation of a clinical index to predict survival in ambula- tory patients referred for cardiac transplant evaluation. Circulation 1997; 95:2660 7. 53. Fonarow GC, Adams KF Jr., Abraham WT, et al. 